THE PHARMACOLOGICAL BASIS OF THE USE OF CALCIUM-ANTAGONIST DRUGS .2.

被引:0
|
作者
THUILLEZ, C
GIUDICELLI, JF
机构
来源
COEUR ET MEDECINE INTERNE | 1980年 / 19卷 / 02期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:219 / 226
页数:8
相关论文
共 50 条
  • [2] Calcium-antagonist drugs
    Abernethy, DR
    Schwartz, JB
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (19): : 1447 - 1457
  • [3] CALCIUM-ANTAGONIST DRUGS
    RESNEKOV, L
    CHEST, 1980, 78 (01) : 121 - 121
  • [4] USE OF CALCIUM-ANTAGONIST DRUGS IN A CARDIOLOGY DEPARTMENT
    PAUX, G
    CHRETIEN, P
    LETAC, B
    BOISMARE, F
    THERAPIE, 1982, 37 (05): : 596 - 598
  • [5] TIAPAMIL, A NEW CALCIUM-ANTAGONIST .2. FURTHER PHARMACOLOGICAL CHARACTERIZATION AND TOXICOLOGY
    EIGENMANN, R
    GEROLD, M
    HEFTI, F
    JOVANOVIC, D
    HAEUSLER, G
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1981, 31-2 (09): : 1401 - 1410
  • [6] MYOCARDIAL PROTECTION BY CALCIUM-ANTAGONIST DRUGS
    DRAKEHOLLAND, AJ
    NOBLE, MIM
    EUROPEAN HEART JOURNAL, 1983, 4 (11) : 823 - 825
  • [7] PHYSIOLOGICAL AND PHARMACOLOGICAL CORRELATES OF CALCIUM-ANTAGONIST RECEPTORS
    WAGNER, JA
    REYNOLDS, IJ
    SNYDER, SH
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 10 : S1 - S9
  • [8] CLINICAL-EVALUATION OF CALCIUM-ANTAGONIST DRUGS
    GHIO, S
    SPECCHIA, G
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 : S71 - S74
  • [9] PULMONARY-HYPERTENSION AND CALCIUM-ANTAGONIST DRUGS
    WIDIMSKY, J
    OSTADAL, B
    URBANOVA, D
    PELOUCH, V
    PROCHAZKA, J
    BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE-CLINICAL RESPIRATORY PHYSIOLOGY, 1982, 18 (04): : P92 - P93
  • [10] DEVELOPMENT AND PHARMACOLOGICAL VALUE OF NANOCAPSULES OF A CALCIUM-ANTAGONIST, DARODIPINE
    HUBERT, B
    ATKINSON, J
    GUERRET, M
    HOFFMAN, M
    DEVISSAGUET, JP
    MAINCENT, P
    5TH INTERNATIONAL CONFERENCE ON PHARMACEUTICAL TECHNOLOGY, VOLS 1-5, 1989, : D15 - D22